Items where authors include "Norris, K"

Article

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Hopes, T, Norris, K, Agapiou, M et al. (5 more authors) (2021) Ribosome heterogeneity in Drosophila melanogaster gonads through paralog-switching. Nucleic Acids Research. ISSN 0305-1048

Norris, K, Hopes, T and Aspden, JL orcid.org/0000-0002-8537-6204 (2021) Ribosome heterogeneity and specialization in development. WIREs RNA, 12 (4). e1644. ISSN 1757-7004

Abani, O, Abbas, A, Abbas, F et al. (4809 more authors) (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, 397 (10289). pp. 2049-2059. ISSN 0140-6736

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

Norris, K, Hillmen, P orcid.org/0000-0001-5617-4403, Rawstron, A orcid.org/0000-0003-0798-9790 et al. (4 more authors) (2019) Telomere length predicts for outcome to FCR chemotherapy in CLL. Leukemia, 33 (8). pp. 1953-1963. ISSN 0887-6924